The 5 th Gago Conference on European Science Policy

[...]. Considerable time should be devoted to setting up a dialogue in each member State on the issue of human resources for science, engineering and technology, helping policy-makers understand what is required, and building bridges between national and European actors. Dialogue between industrial and academic organizations in Europe should also be pursued.

José Mariano Gago In "Europe needs more scientists", European Commission, Brussels, 2004


Heidelberg

October 6 th 2022

PROGRAMME

The Gago Conferences on European Science Policy

The Gago Conferences on European Science Policy provide an international forum to strengthen the debate on emerging issues of research and innovation policy in Europe, as well as to promote the necessary involvement of major stakeholders in policy making and the diffusion of knowledge in science education and culture. The Conferences seek also to strengthen international scientific and technological cooperation networking in Europe towards a positive impact on a global scale.Science and technology (S&T) are key global resources for our collective future, our wealth, job creation and shared prosperity, both at home and abroad. The impact of S&T and innovation are the result of a cumulative, long-term, collective and uncertainty process, involving an extensive division of labour, which requires massifying the training of human resources and qualifying the labour force in many economic sectors. Increasing interest in these processes has been driving innovative research and practice across a wide range of businesses and academic disciplines - from management, marketing, engineering and economics to public policy, sociology, history and law.

"Science is a battle ground, it´s not neutral.And if you know it´s not neutral, it becomes interesting.It can become part of the modern youth culture.You must choose between generosity and greed,between peace and war,and choose between disclosing or hiding the truth"...

José Mariano Gago (2001)

The primary objective of these conferences is to bring together leading representatives from academic, business, social, culture and government sectors worldwide to present and discuss current and future issues of critical importance for European science and technology, including their impact to foster social and economic development and shared prosperity both at home and abroad. Multidisciplinary perspectives are encouraged to provide state-of-the-art and useful knowledge to decision makers in the private, public and social sectors - including informed and effective education, culture, business, government policies and strategies for Europe.

Cancer research: society at the frontiers of knowledge

5th Gago Conference on European Science Policy

A joint organization of Ciencia Viva and the German Cancer Research Center (DKFZ)

DKFZ , Heidelberg, 6th October, 2022

Cancer is a major and growing societal challenge, putting an immense pressure on European health systems as 3.5 million people are diagnosed with this disease every year. If no further action is taken to prevent it, this number is expected to grow due to increased longevity, unhealthy lifestyles and environmental conditions. On the other hand, more people will live longer with cancer, following the recent introduction of personalized treatment and care, often at the frontiers of knowledge.

The Horizon Europe Mission on Cancer has ambitious goals to deliver tangible results by 2030. Achieving those results will require that research and innovation is combined with new forms of governance and collaboration, as well as with citizens´ engagement.

Some of the Mission´s objectives – like understanding cancer mechanisms and creating new techniques for diagnosis and treatment - are directly related to the development of research and innovation. Other objectives like prevention and early detection or improving the quality of life for patients and their families have a more societal nature and require citizens` engagement with cancer research.

Policies should be created to:

  • Promote healthy lifestyles, namely regarding food and exercise
  • Promote screening programmes for early detection
  • Promote social change regarding cancer patients and their better inclusion in society

informing and empowering citizens to improve their health and well-being and contributing for a better inclusion of cancer patients in society. Science centres, patient associations, NGOs, along with research laboratories, can be mobilized to design and deploy programmes to achieve citizens´ engagement with cancer research.

The Gago Conferences on European Science Policy provide an international forum to strengthen the debate on emerging issues of research and innovation policy in Europe, as well as to promote the necessary involvement of major stakeholders in policy making and the diffusion of knowledge in science education and culture. The Conferences seek also to strengthen international scientific and technological cooperation networking in Europe towards a positive impact on a global scale.

  Four years after the first Gago Conference on Science Policy, in Porto, the Heidelberg Conference will revisit the advances of Cancer Research and the societal challenges to ensure that the Mission on Cancer achieves the desired impact by 2030.

Organizing Committee:

  • Manuel Heitor , IN+/IST - Center for Innovation, Technology and Policy Research, University of Lisbon; former Minister for Science, Technology and Higher Education, Portugal
  • Julio E. Celis , Guest Researcher at the DCRC-Danish Cancer Society Research Center, Copenhagen, Denmark; EACS - European Academy of Cancer Sciences
  • Michael Baumann , Chairman and Scientific Director of DKFZ – German Cancer Research Center; EACS-European Academy of Cancer Sciences 
  • Manuel Sobrinho Simões , emeritus, i3S/Ipatimup, Porto Comprehensive Cancer Centre, University of Porto, Portugal
  • Helena Canhão , NOVA School of Medicine, Portugal; Patient Innovation
  • Pedro Oliveira , Copenhagen Business School, Denmark; Patient Innovation
  • Rosalia Vargas , President of Ciência Viva, Portugal

Target participants:

  • Members of the European Parliament
  • European Commission, particularly DG Research and Innovation
  • European policy makers
  • Advisors, academics and other representatives from research institutions

International Secretariat:

Ciência Viva Agency, Lisbon, Portugal

 

___________

Organization:

ISE - Initiative for Science in Europe Ciência Viva

Programme (draft)

(Time zone CEST)


6 th October 2022

9:00 - Welcome and Opening Remarks

  • Michael Baumann, Chairman and Scientific Director of DKFZ – German Cancer Research Center; and EACS - European Academy of Cancer Sciences 
  • Rosalia Vargas, President of Ciência Viva, Portugal
  • Manuel Heitor,  IN+/IST - Center for Innovation, Technology and Policy Research, University of Lisbon; and former Minister for Science, Technology and Higher Education, Portugal

9:10  - Session 1: Emerging developments in European cancer policy

Chair:

  • Manuel Heitor,  IN+/IST and former Minister for Science, Technology and Higher Education, Portugal

Brief initial interventions: 5-7 min each

  • Stella Kyriakides, EU Commissioner for Health and Food Safety(Video Message, tbc)
  • Mario Brandenburg, Parliamentary States Secretary, Ministry of Research and Education, Germany (tbc)
  • Angel Font, La Caixa Foundation Barcelona, Spain; President and European Foundation Centre
  • Francesco De Lorenzo, ECPC - European Cancer Patient Coalition 
  • Jeliazko Arabadjiev, Bulgarian Scientific Society of Immuno-Oncology 

 

Bridging the gaps between research and healthcare delivery

Keynote Speech

  • Ulrik Ringborg, EACS 

Chair:

  • Julio E. Celis, DCRC and EACS

10:30 - Coffee Break


10:45 - Session 2: Understanding cancer

Chair: 

  • Eric Solary, Inserm- National Institute of Health and Medical Research, France

Speakers: 

  • Eric Solary, Inserm
  • Christine Chomienne, Université de Paris (tbc)
  • Lena Maier-Hein, DKFZ

Roundtable:

  • Alexander Eggermont, Princess Máxima Center, The Netherlands
  • Elisabete Weiderpass, IARC - International Agency for Research on Cancer 
  • Michael Boutros, DKFZ
  • Pedro Oliveira, Patient Innovation, Copenhagen Business School (tbc)

Discussion


12:30 -   Lunch break


13:15 - Session 3: Interconnected high-quality infrastructures for translational research, clinical and prevention trials, and outcomes research

Chair:

  • Anton Berns, EACS

Speakers:

  • Alexander Eggermont, Princess Maxima Center, The Netherlands
  • Joachim Schüz, IARC Infrastructures for translational prevention research
  • Elena Garralda, VHIO - Val d´Hebron Institute of Oncology, Spain Clinical trials required for implementation
  • Nils Wilking, Karolinska Institutet, Sweden Infrastructures for outcomes research

Roundtable :

  • Simon Oberst, OECI - Organization of European Cancer Institutes
  • Stéphane Lejeune, EORTC-European Organization for Research and Treatment of Cancer 
  • Francoise Meunier, EACS
  • Margarida Goulart, Joint Research Centre, European Commission (tbc)
  • Margarita Kirienko, IRCCS Foundation Istituto Nazionale dei Tumori, Italy (tbc)

Discussion


15:00 - Coffee break


15:15 - Session 4: Digital transition in cancer

Chair:

  • Marc Lawler, Queen´s University, Belfast, United Kingdom

Speakers:

  • Alfonso Valencia, Barcelona Super Computing Center, Spain Big data and AI in cancer research
  • Fátima Carneiro, University of Porto, São João Hospital and Ipatimup/i3S, Portugal;Chair of the European Society of Pathology Advisory Board Digital patology
  • Marc Lawler, Queen´s University Belfast, United Kingdom Creating a culture of shared data

Roundtable :

  • Helena Canhão, Nova Medical School, Portugal and Patient Innovation
  • Markus Wartenberg, Chair of the National Center for Tumor Disease (NCT), Germany  
  • Jolanta Kunikowska, European Association of Nuclear Medicine, (tbc)

Discussion

16:15 - Session 5:   Functional networks of Comprehensive Cancer Centers (CCCs) and other centres: Structuring cancer activities in Member States

Chair:

  • Michael Baumann, DKFZ

Speakers:

  • Michael Baumann, DKFZ 
  • Tit Albreht, National Institute of Public Health of Slovenia
  • Paolo Casali, Istituto Nazionale Tumori, Italy (tbc)
  • Pamela Kearns, SIOPE - European Society for Paediatric Oncology (tbc)

Roundtable :

  • Rui Henrique , IPOPORTO - Portuguese Institute of Oncology of Porto Francisco Gentil , Portugal
  • Peter Nagy, Central–Eastern European Academy of Oncology, Hungary
  • Hildegarde Vandenhove, MEENAS - Consortium of European Radiation Research (tbc)

Discussion

17: 45 -   Concluding remarks

  • Michael Baumann, DKFZ and EACS
  • Julio Celis, DCRC and EACS
  • Rosalia Vargas, Ciencia Viva

18:00 - Adjourned, cheese and wine

Venue

German Cancer Research Center (DKFZ)

Communication Center

Address:

Im Neuenheimer Feld 280

D-69120 Heidelberg

 

Useful information